Immediate Impact
5 by Nobel laureates 37 from Science/Nature 61 standout
Citing Papers
Renal Cell Carcinoma
2024 Standout
Renal cell carcinoma
2024 Standout
Works of Scott S. Tykodi being referenced
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial
2022
Nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma (nccRCC): Safety and efficacy from CheckMate 920.
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Scott S. Tykodi | 1796 | 1177 | 1155 | 104 | 3.0k | |
| Salvador Martín‐Algarra | 2212 | 906 | 1319 | 141 | 3.8k | |
| Suxia Luo | 1918 | 765 | 1236 | 105 | 3.3k | |
| Angela Märten | 2224 | 1436 | 905 | 134 | 3.3k | |
| Frédéric Di Fiore | 2016 | 719 | 1348 | 117 | 3.9k | |
| Gordana Vlahovic | 2148 | 942 | 897 | 92 | 3.8k | |
| Sean P. Pitroda | 1693 | 988 | 1083 | 94 | 3.3k | |
| Thomas Olencki | 1991 | 1701 | 1515 | 120 | 3.8k | |
| Shuang Qin | 2035 | 634 | 1295 | 71 | 3.7k | |
| Maresa Altomonte | 2035 | 835 | 1576 | 94 | 4.3k | |
| Noel F.C.C. de Miranda | 1949 | 478 | 1285 | 111 | 3.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...